Hyperprolactinaemia
Hyperprolactinaemia is a condition for which cabergoline is used. Prolactinoma is also listed as a use for cabergoline. Dostinex tablets contain cabergoline in 0.25 mg and 0.5 mg strengths.
Medicine used to treat Hyperprolactinaemia
Key points
- Cabergoline is the active ingredient in Dostinex.
- Dostinex is supplied as tablets.
- Pharmacy partners in India ship orders to Malaysia in discreet packaging.
Cabergoline and the named conditions
Cabergoline is used for hyperprolactinaemia and prolactinoma. The ingredient is also listed as cabergoline. Both terms appear as separate uses for cabergoline. A doctor can explain which term applies to an individual case and whether cabergoline is suitable. If you have been given cabergoline, follow the instructions from your doctor and raise any concerns with them.
Dostinex tablets
Dostinex is the tablet brand of cabergoline. It is available in 0.25 mg and 0.5 mg strengths. These tablet strengths are listed for hyperprolactinaemia and prolactinoma. The product is supplied as tablets in both strengths.
Treatment and supervision
Cabergoline treatment is used in hyperprolactinaemia and prolactinoma. A doctor can confirm whether the medicine is appropriate for an individual case. Do not start, stop or change a medicine without medical advice. If you are already using cabergoline, keep to the instructions you have been given and report any problems to your doctor. Bring any questions about your treatment to your next appointment.
When to seek advice
Speak with a doctor if you have questions about hyperprolactinaemia, prolactinoma or cabergoline. Seek advice if you are unsure whether Dostinex is suitable for you. Do not use medicine that was supplied for someone else.
Further reading
Last updated